Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Anticancer Agent 118, an N‑acylated ciprofloxacin derivative, exhibits antibacterial efficacy against Gram-positive strains and antiproliferative effects on prostate PC3 cells, making it a potential candidate for antitumor research [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 1,520.00 | |
50 mg | 8-10 weeks | $ 1,980.00 | |
100 mg | 8-10 weeks | $ 2,500.00 |
Description | Anticancer Agent 118, an N‑acylated ciprofloxacin derivative, exhibits antibacterial efficacy against Gram-positive strains and antiproliferative effects on prostate PC3 cells, making it a potential candidate for antitumor research [1]. |
In vitro | Anticancer agent 118 (Compound 3) (0-100 μM; 72 hours) exhibits potent antiproliferative activity against prostate cancer PC3 cells and induces apoptosis/necrosis in these cells [1]. |
Molecular Weight | 407.82 |
Formula | C19H19ClFN3O4 |
CAS No. | 864443-43-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Anticancer agent 118 864443-43-6 inhibitor inhibit